In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 22625-57-6, name is 5-(Chloromethyl)oxazolidin-2-one, introducing its new discovery. Application In Synthesis of 5-(Chloromethyl)oxazolidin-2-one
Antibiotic sulfonylaminocarbonyl activated beta-lactams
This invention presents novel 2-azetidinone compounds which are useful as antibacterial agents to eradicate or control susceptible microbes of the formula STR1 wherein R401 and R402 are the same or different and are (a) hydrogen, (b) (C1 -C12) alkyl (c) (C2 -C8) alkenyl, (d) (C2 -C8) alkynyl, (e) (C3 -C10) cycloalkyl, (f) phenyl optionally substituted with from one to 3 substituents selected from the group consisting of halogen, hydroxy, amino, nitro, (C1 -C4) alkyl, and (C1 -C4) alkoxy, (g) benzyl optionally substituted with from one to 3 substituents selected from the group consisting of halogen, hydroxy, amino, nitro, (C1 -C4) alkyl, and (C1 -C4) alkoxy, (h) –CH2 –O–CO–CH2 –NHR420, (i) –CH2 –O–CO2 –R430, (j) –CH2 F, or (k) –CHF2 ; wherein R420 is (a) hydrogen, (b) –COH, or (c) –CO–O–C(CH3)3 ; wherein R430 is (C1 -C8) alkyl, –(CH2) 2 OC(O)NH2, –(CH 2)2 Cl, –(CH2)2 OCH3 or –(CH2)2 NHCOH; wherein R300 is an acyl group derived from a carboxylic acid; wherein R100 is an optionally substituted heterocyclic moiety of Formula 2, 3, 4 or 5 STR2
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 22625-57-6, and how the biochemistry of the body works.Application In Synthesis of 5-(Chloromethyl)oxazolidin-2-one
Reference£º
Oxazolidine – Wikipedia,
Oxazolidine | C3H1406NO – PubChem